Skip to main content

AACR: High-Throughput Compound Testing

Premium

At the American Association for Cancer Research's annual meeting in Chicago last week, the Novartis Institute for BioMedical Research's William Sellers spoke about the importance of finding the right combinations of drugs to treat different kinds of cancer. "One drug is never enough," he said during his talk at the opening plenary session.

Finding the right combinations can be "daunting," he added. But companies like Novartis are developing ways to make the process more efficient. Sellers showed a short clip of a high-throughput robotic system that he says can test 1,500 compounds on 600 different cancer cell lines in just three months, in order to see if these compounds have any therapeutic effect.

(Video courtesy of William Sellers)

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.